MINDMED
MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses. The company is assembling a compelling drug development pipeline of innovative treatments based on psychedelic substances including Psilocybin, LSD, MDMA, DMT, and an Ibogaine derivative, 18-MC. It was founded in 2019 and headquartered in New York, United States.
MINDMED
Industry:
Biotechnology Health Care Pharmaceutical
Founded:
2019-05-30
Address:
New York, New York, United States
Country:
United States
Website Url:
http://www.mindmed.co
Total Employee:
11+
Status:
Active
Total Funding:
175.82 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Analytics LetsEncrypt Google Tag Manager WordPress Google Universal Analytics Domain Not Resolving
Similar Organizations
Acclinate
Acclinate is a digital health company helping pharma diversify clinical trials by accessing and engaging communities of color.
Apellis Pharmaceuticals
Apellis Pharmaceuticals focuses on developing novel therapeutics and drug delivery technologies to address chronic inflammatory diseases.
Arcellx
Arcellx is a clinical-stage biotechnology company that provides patients with immune cell therapies.
ArriVent Biopharma
ArriVent develops pharmaceutical products to cure presently untreatable cancer.
Cardior Pharmaceuticals
Cardior Pharmaceuticals discovers and develops medicines and therapeutics for the treatment and prevention of heart disease.
Cybin
Cybin is a life sciences company dedicated in advancing psychedelic therapeutics with the goal of transforming mental healthcare.
Day One Biopharmaceuticals
Day One Biopharmaceuticals is a biotechnology company that focuses on developing new cancer therapies for patients of all ages.
Emmaus Medical
Emmaus Medical is a pharmaceutical company developing new treatments for rare diseases and conditions.
ENSURE
ENSURE is an e-commerce company that provides medicines and health products.
Entegrion
Entegrion is a life sciences company dedicated to providing innovative solutions.
Ervaccine Technologies
Ervaccine Technologies a developer of next-generation cancer vaccines that targets endogenous retroviruses.
Genomic Prediction
Genomic Prediction provides advanced genetic testing for IVF.
GlyTech
GlyTech is a responsibility of the company to protect personal information in its business activities.
Integrated Environmental Technologies
IET is a life sciences firm committed to providing advanced technologies to pressing environmental and health problems.
Procera
Procera is a cognitive health brand, developing and innovating around a line of products designed to support brain health.
MabGenesis
MabGenesis is a biopharmaceutical company that provides therapeutic monoclonal antibody drugs in human and animal fields.
MedFilm
MedFilm business idea is to convey information about surgical interventions to patients through animation and film.
Mucommune
Mucommune is a privately-held preclinical stage company launched based on the “muco-trapping” monoclonal antibodies (mAb) platform.
Pilgrim Soul
Pilgrim Soul is a mission driven cannabis brand focused on optimizing human creative performance to gain a competitive edge.
Psilera Bioscience
Psilera Bioscience reimagining psychoactive natural products as building blocks for a new generation of mindful medicine.
Recro Pharma
Recro Pharma is a pharmaceutical company developing non-opioid therapeutics for the treatment of pain.
Regenosine, Inc
Regenosine is developing a first-in-class disease-modifying regenerative therapy for osteoarthritis.
Roivant Sciences
Roivant Sciences is a biopharmaceutical company focused on the development of medicines and healthcare technologies to patients.
Silo Wellness
Silo Wellness operates psychedelic clinics and develops legal functional mushroom consumer products.
St. Teresa Medical
St. Teresa Medical is a medical applications developing company commercializing a hemostatic technology platform called FASTCLOT.
Trobix Bio
Trobix Bio is a company that develops and commercializes antibacterial products.
TTS Pharma
TTS Pharma is a UK-based biotechnology company developing technologies to support the pharmacogenetic stratification of patients.
Current Advisors List
Current Employees Featured
Founder
Stock Details
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2021-02-18 | HealthMode | HealthMode acquired by MindMed | 41.3 M CAD |
Investors List
Canaccord Genuity Group
Canaccord Genuity Group investment in Post-IPO Equity - MindMed
Eight Capital
Eight Capital investment in Post-IPO Equity - MindMed
Canaccord Genuity Group
Canaccord Genuity Group investment in Post-IPO Equity - MindMed
CIBC
CIBC investment in Post-IPO Equity - MindMed
Eight Capital
Eight Capital investment in Post-IPO Equity - MindMed
Canaccord Genuity Group
Canaccord Genuity Group investment in Post-IPO Equity - MindMed
Canaccord Genuity Group
Canaccord Genuity Group investment in Post-IPO Equity - MindMed
Dan Capelle
Dan Capelle investment in Post-IPO Equity - MindMed
BT Growth Capital
BT Growth Capital investment in Post-IPO Equity - MindMed
James Bailey
James Bailey investment in Post-IPO Equity - MindMed
Newest Events participated
Participated in Never Alone Summit
on 2021-05-21 as speaker
Key Employee Changes
Official Site Inspections
http://www.mindmed.co Semrush global rank: 781.37 K Semrush visits lastest month: 50.58 K
- Host name: 141.193.213.21
- IP address: 141.193.213.21
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "MindMed"
About :: Mind Medicine (MindMed) Inc. (MNMD)
MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that unlock new opportunities to …See details»
MindMed - Wikipedia
Mind Medicine (MindMed) Inc., doing business as MindMed, is a New York -based biotechnology company that is currently developing clinical and therapeutic applications for psychedelic and, …See details»
Leadership | MindMed
Meet MindMed's team of experts, who are at the core of our mission to be the global leader in brain health treatment.See details»
MindMed Receives FDA Breakthrough Therapy …
Mar 7, 2024 MindMed is developing MM120 (lysergide D-tartrate), the tartrate salt form of lysergide, for GAD and is exploring its potential applications in other serious brain health disorders. About MindMed MindMed is a clinical stage …See details»
MindMed - Crunchbase Company Profile & Funding
MindMed provides psychedelic-inspired medicines and therapies for substance abuse disorders and other mental illnesses.See details»
MindMed Announces Chief Executive Officer Transition
Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (DE: MMQ) (the “Company”), a leading clinical-stage pharmaceutical company and pioneer in the field of psychedelic …See details»
MindMed - LinkedIn
MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology. Our …See details»
Mind Medicine (MindMed) Inc. (MNMD)
Mar 17, 2025 MindMed is a clinical stage biopharmaceutical company developing novel product candidates to treat brain health disorders. Our mission is to be the global leader in the development and delivery of treatments that …See details»
MindMed Announces New Employee Inducement Grants
12 hours ago MindMed Announces New Employee Inducement Grants For Media: [email protected] For Investors: [email protected] Mind Medicine (MindMed) Inc. (NASDAQ: …See details»
MindMed Company Profile - Office Locations, Competitors ... - Craft
MindMed has 5 employees at their 1 location and $6.2 m in total funding,. See insights on MindMed including office locations, competitors, revenue, financials, executives, subsidiaries …See details»
MindMed - LinkedIn
MindMed is a clinical-stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, addiction, pain and neurology.See details»
Mind Medicine (MindMed) Inc. Completes Reverse Takeover …
Feb 28, 2020 About Mind Medicine (MindMed) Inc. Mind Medicine (MindMed) Inc. is a neuro-pharmaceutical company that discovers, develops and deploys psychedelic inspired medicines …See details»
MindMed Closes Upsized Financing of CAD $92.1m (USD $72.7m …
Jan 7, 2021 The MindMed executive team brings extensive biopharmaceutical experience to the Company's groundbreaking approach to developing the next-generation of psychedelic …See details»
MindMed Announces First Patient Dosed in Phase 3 Emerge Study …
6 days ago NEW YORK-- (BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the "Company" or "MindMed"), a late-stage clinical biopharmaceutical company …See details»
MindMed Strengthens Board with Appointment of Two New …
Aug 12, 2022 About MindMed MindMed is a clinical stage biopharmaceutical company developing novel products to treat brain health disorders, with a particular focus on psychiatry, …See details»
MindMed Announces First Patient Dosed in Phase 3 Emerge
6 days ago NEW YORK-- (BUSINESS WIRE)--Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company …See details»
MindMed Reports Full Year 2022 Financial Results and Business ...
NEW YORK, March 9, 2023 — Mind Medicine (MindMed) Inc. (NASDAQ: MNMD), (NEO: MMED), (the “Company” or “MindMed”), a clinical stage biopharmaceutical company …See details»
MindMed - LinkedIn
MindMed is a company committed to creating and distributing innovative and affordable neurocognitive therapeutic apps to help in the treatment of mental illnesses.See details»
MindMed Announces New Employee Inducement Grants
13 hours ago NEW YORK-- (BUSINESS WIRE)-- Mind Medicine (MindMed) Inc. (NASDAQ: MNMD) (the “Company” or “MindMed”), a late-stage clinical biopharmaceutical company …See details»
MindMed Reports Full Year 2021 Financial Results and Business ...
Mar 28, 2022 “2021 was a year of major advancements across all aspects of MindMed, with significant growth in our organization, development programs and research collaborations.See details»